Fig. 1From: Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemiaComparative potency of BCR-ABL1 inhibition and selected off-target activity of tyrosine kinase inhibitors (TKIs). The figure describes the relative potencies of the various TKIs for BCR-ABL inhibition, as well as selected off-target activity of the various TKIs. Arrow width indicates potency. See text for further discussionBack to article page